Pharsight

Pizensy patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10806743 BRAINTREE LABS Method of administering lactitol to reduce plasma concentration of lactitol
May, 2037

(12 years from now)

Pizensy is owned by Braintree Labs.

Pizensy contains Lactitol.

Pizensy has a total of 1 drug patent out of which 0 drug patents have expired.

Pizensy was authorised for market use on 12 February, 2020.

Pizensy is available in for solution;oral dosage forms.

Pizensy can be used as method of treating chronic idiopathic constipation in adult patients..

Drug patent challenges can be filed against Pizensy from 13 February, 2024.

The generics of Pizensy are possible to be released after 12 May, 2037.

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Feb 12, 2025

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using LACTITOL ingredient

NCE-1 date: 13 February, 2024

Market Authorisation Date: 12 February, 2020

Treatment: Method of treating chronic idiopathic constipation in adult patients.

Dosage: FOR SOLUTION;ORAL

More Information on Dosage

PIZENSY family patents

Family Patents